Follow the people · Insider
Joseph Burnett
Joseph Burnett files insider transactions with the SEC as a ceo and president of ClearPoint Neuro (CLPT). We hold 5 disclosed purchases and sales filed since 7 November 2017, 2 of them in the last 90 days.
- Files forCLPT
- Disclosed buys and sells5 in all, 2 in the last 90 days
- Last disclosure3 September 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 7 May 2020 — 2 September 2026CEO and President · ClearPoint Neuro (CLPT)94 Form 4 lines · source: SEC Form 4
- Filed 7 November 2017 — 7 February 2020CEO and President · Mri Interventions (MRIC)17 Form 4 lines · source: SEC Form 4
Everything they disclosed
111 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 12,517 shares of ClearPoint NeuroSEC Form 43 September 2026Common Stock · traded 2 September 2026 · filed 3 September 2026
- exercised options over 12,517 shares of ClearPoint Neuro (a derivative holding)SEC Form 43 September 2026Stock Options (right to buy) · traded 2 September 2026 · filed 3 September 2026
- was granted 1,361 shares of ClearPoint NeuroSEC Form 42 July 2026Common Stock · traded 30 June 2026 · filed 2 July 2026
- exercised options over 20,000 shares of ClearPoint NeuroSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 20,000 shares of ClearPoint NeuroSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- exercised options over 20,000 shares of ClearPoint Neuro (a derivative holding)SEC Form 41 July 2026Stock Options (right to buy) · traded 29 June 2026 · filed 1 July 2026
- exercised options over 60,000 shares of ClearPoint NeuroSEC Form 422 June 2026Common Stock · traded 17 June 2026 · filed 22 June 2026
- ▼ sold on the open market 60,000 shares of ClearPoint NeuroSEC Form 422 June 2026Common Stock · traded 17 June 2026 · filed 22 June 2026
- ▼ sold on the open market 1,843 shares of ClearPoint NeuroSEC Form 422 June 2026Common Stock · traded 17 June 2026 · filed 22 June 2026
- exercised options over 60,000 shares of ClearPoint Neuro (a derivative holding)SEC Form 422 June 2026Stock Options (right to buy) · traded 17 June 2026 · filed 22 June 2026
- exercised options over 20,942 shares of ClearPoint NeuroSEC Form 420 March 2026Common Stock · traded 19 March 2026 · filed 20 March 2026
- exercised options over 20,942 shares of ClearPoint Neuro (a derivative holding)SEC Form 420 March 2026Stock Options (right to buy) · traded 19 March 2026 · filed 20 March 2026
- exercised options over 20,942 shares of ClearPoint Neuro (a derivative holding)SEC Form 420 March 2026Stock Options (right to buy) · traded 19 March 2026 · filed 20 March 2026
- exercised options over 20,942 shares of ClearPoint NeuroSEC Form 420 March 2026Common Stock · traded 19 March 2026 · filed 20 March 2026
- exercised options over 84,829 shares of ClearPoint NeuroSEC Form 416 March 2026Common Stock · traded 12 March 2026 · filed 16 March 2026
- had shares withheld for tax on 43,161 shares of ClearPoint NeuroSEC Form 416 March 2026Common Stock · traded 12 March 2026 · filed 16 March 2026
- exercised options over 84,829 shares of ClearPoint Neuro (a derivative holding)SEC Form 416 March 2026Restricted Stock Units · traded 12 March 2026 · filed 16 March 2026
- exercised options over 84,829 shares of ClearPoint Neuro (a derivative holding)SEC Form 416 March 2026Restricted Stock Units · traded 12 March 2026 · filed 16 March 2026
- exercised options over 84,829 shares of ClearPoint NeuroSEC Form 416 March 2026Common Stock · traded 12 March 2026 · filed 16 March 2026
- had shares withheld for tax on 43,161 shares of ClearPoint NeuroSEC Form 416 March 2026Common Stock · traded 12 March 2026 · filed 16 March 2026
- exercised options over 47,407 shares of ClearPoint NeuroSEC Form 410 March 2026Common Stock · traded 6 March 2026 · filed 10 March 2026
- had shares withheld for tax on 22,709 shares of ClearPoint NeuroSEC Form 410 March 2026Common Stock · traded 6 March 2026 · filed 10 March 2026
- exercised options over 47,407 shares of ClearPoint Neuro (a derivative holding)SEC Form 410 March 2026Restricted Stock Units · traded 6 March 2026 · filed 10 March 2026
- exercised options over 47,407 shares of ClearPoint Neuro (a derivative holding)SEC Form 410 March 2026Restricted Stock Units · traded 6 March 2026 · filed 10 March 2026
- exercised options over 47,407 shares of ClearPoint NeuroSEC Form 410 March 2026Common Stock · traded 6 March 2026 · filed 10 March 2026
- had shares withheld for tax on 22,709 shares of ClearPoint NeuroSEC Form 410 March 2026Common Stock · traded 6 March 2026 · filed 10 March 2026
- exercised options over 26,568 shares of ClearPoint NeuroSEC Form 45 March 2026Common Stock · traded 3 March 2026 · filed 5 March 2026
- had shares withheld for tax on 9,533 shares of ClearPoint NeuroSEC Form 45 March 2026Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 26,568 shares of ClearPoint Neuro (a derivative holding)SEC Form 45 March 2026Restricted Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 26,568 shares of ClearPoint Neuro (a derivative holding)SEC Form 45 March 2026Restricted Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 26,568 shares of ClearPoint NeuroSEC Form 45 March 2026Common Stock · traded 3 March 2026 · filed 5 March 2026
- had shares withheld for tax on 9,533 shares of ClearPoint NeuroSEC Form 45 March 2026Common Stock · traded 3 March 2026 · filed 5 March 2026
- ▼ sold on the open market 19,951 shares of ClearPoint NeuroSEC Form 426 February 2026Common Stock · traded 25 February 2026 · filed 26 February 2026
- ▼ sold on the open market 19,951 shares of ClearPoint NeuroSEC Form 426 February 2026Common Stock · traded 25 February 2026 · filed 26 February 2026
- was granted 147,275 shares of ClearPoint Neuro (a derivative holding)SEC Form 419 February 2026Restricted Stock Units · traded 17 February 2026 · filed 19 February 2026
- was granted 147,275 shares of ClearPoint Neuro (a derivative holding)SEC Form 419 February 2026Restricted Stock Units · traded 17 February 2026 · filed 19 February 2026
- ▼ sold on the open market 2,943 shares of ClearPoint NeuroSEC Form 427 January 2026Common Stock · traded 26 January 2026 · filed 27 January 2026
- ▼ sold on the open market 2,943 shares of ClearPoint NeuroSEC Form 427 January 2026Common Stock · traded 26 January 2026 · filed 27 January 2026
- exercised options over 20,000 shares of ClearPoint NeuroSEC Form 413 January 2026Common Stock · traded 9 January 2026 · filed 13 January 2026
- ▼ sold on the open market 20,000 shares of ClearPoint NeuroSEC Form 413 January 2026Common Stock · traded 9 January 2026 · filed 13 January 2026
- exercised options over 20,000 shares of ClearPoint Neuro (a derivative holding)SEC Form 413 January 2026Stock Options (right to buy) · traded 9 January 2026 · filed 13 January 2026
- exercised options over 20,000 shares of ClearPoint Neuro (a derivative holding)SEC Form 413 January 2026Stock Options (right to buy) · traded 9 January 2026 · filed 13 January 2026
- exercised options over 20,000 shares of ClearPoint NeuroSEC Form 413 January 2026Common Stock · traded 9 January 2026 · filed 13 January 2026
- ▼ sold on the open market 20,000 shares of ClearPoint NeuroSEC Form 413 January 2026Common Stock · traded 9 January 2026 · filed 13 January 2026
- was granted 254 shares of ClearPoint NeuroSEC Form 45 January 2026Common Stock · traded 31 December 2025 · filed 5 January 2026
- was granted 254 shares of ClearPoint NeuroSEC Form 45 January 2026Common Stock · traded 31 December 2025 · filed 5 January 2026
- ▼ sold on the open market 17,583 shares of ClearPoint NeuroSEC Form 414 October 2025Common Stock · traded 10 October 2025 · filed 14 October 2025
- ▼ sold on the open market 6,599 shares of ClearPoint NeuroSEC Form 414 October 2025Common Stock · traded 10 October 2025 · filed 14 October 2025
- ▼ sold on the open market 1,981 shares of ClearPoint NeuroSEC Form 414 October 2025Common Stock · traded 10 October 2025 · filed 14 October 2025
- ▼ sold on the open market 300 shares of ClearPoint NeuroSEC Form 414 October 2025Common Stock · traded 10 October 2025 · filed 14 October 2025
- was granted 1,424 shares of ClearPoint NeuroSEC Form 42 July 2025Common Stock · traded 30 June 2025 · filed 2 July 2025
- had shares withheld for tax on 15,476 shares of ClearPoint NeuroSEC Form 412 June 2025Common Stock · traded 10 June 2025 · filed 12 June 2025
- ▼ sold on the open market 21,247 shares of ClearPoint NeuroSEC Form 411 June 2025Common Stock · traded 9 June 2025 · filed 11 June 2025
- exercised options over 42,414 shares of ClearPoint Neuro (a derivative holding)SEC Form 414 March 2025Restricted Stock Units · traded 12 March 2025 · filed 14 March 2025
- exercised options over 42,414 shares of ClearPoint NeuroSEC Form 414 March 2025Common Stock · traded 12 March 2025 · filed 14 March 2025
- had shares withheld for tax on 23,405 shares of ClearPoint NeuroSEC Form 414 March 2025Common Stock · traded 12 March 2025 · filed 14 March 2025
- exercised options over 47,407 shares of ClearPoint Neuro (a derivative holding)SEC Form 410 March 2025Restricted Stock Units · traded 6 March 2025 · filed 10 March 2025
- exercised options over 47,407 shares of ClearPoint NeuroSEC Form 410 March 2025Common Stock · traded 6 March 2025 · filed 10 March 2025
- had shares withheld for tax on 26,160 shares of ClearPoint NeuroSEC Form 410 March 2025Common Stock · traded 6 March 2025 · filed 10 March 2025
- was granted 132,841 shares of ClearPoint Neuro (a derivative holding)SEC Form 44 March 2025Restricted Stock Units · traded 3 March 2025 · filed 4 March 2025
- was granted 251 shares of ClearPoint NeuroSEC Form 43 January 2025Common Stock · traded 31 December 2024 · filed 3 January 2025
- had shares withheld for tax on 3,236 shares of ClearPoint NeuroSEC Form 421 August 2024Common Stock · traded 20 August 2024 · filed 21 August 2024
- was granted 3,500 shares of ClearPoint NeuroSEC Form 42 July 2024Common Stock · traded 28 June 2024 · filed 2 July 2024
- had shares withheld for tax on 14,003 shares of ClearPoint NeuroSEC Form 411 June 2024Common Stock · traded 10 June 2024 · filed 11 June 2024
- was granted 212,071 shares of ClearPoint Neuro (a derivative holding)SEC Form 422 May 2024Restricted Stock Units · traded 20 May 2024 · filed 22 May 2024
- exercised options over 23,704 shares of ClearPoint Neuro (a derivative holding)SEC Form 48 March 2024Restricted Stock Units · traded 6 March 2024 · filed 8 March 2024
- exercised options over 23,704 shares of ClearPoint NeuroSEC Form 48 March 2024Common Stock · traded 6 March 2024 · filed 8 March 2024
- had shares withheld for tax on 11,066 shares of ClearPoint NeuroSEC Form 48 March 2024Common Stock · traded 6 March 2024 · filed 8 March 2024
- was granted 1,067 shares of ClearPoint NeuroSEC Form 43 January 2024Common Stock · traded 29 December 2023 · filed 3 January 2024
- had shares withheld for tax on 6,122 shares of ClearPoint NeuroSEC Form 411 July 2023Common Stock · traded 9 July 2023 · filed 11 July 2023
- was granted 2,095 shares of ClearPoint NeuroSEC Form 45 July 2023Common Stock · traded 30 June 2023 · filed 5 July 2023
- had shares withheld for tax on 6,952 shares of ClearPoint NeuroSEC Form 413 June 2023Common Stock · traded 10 June 2023 · filed 13 June 2023
- was granted 39,506 shares of ClearPoint Neuro (a derivative holding)SEC Form 48 March 2023Stock Options (right to buy) · traded 6 March 2023 · filed 8 March 2023
- was granted 118,518 shares of ClearPoint Neuro (a derivative holding)SEC Form 48 March 2023Restricted Stock Units · traded 6 March 2023 · filed 8 March 2023
- had shares withheld for tax on 1,457 shares of ClearPoint NeuroSEC Form 423 August 2022Common Stock · traded 20 August 2022 · filed 23 August 2022
- had shares withheld for tax on 7,778 shares of ClearPoint NeuroSEC Form 416 August 2022Common Stock · traded 15 August 2022 · filed 16 August 2022
- ▼ sold on the open market 18,867 shares of ClearPoint NeuroSEC Form 416 August 2022Common Stock · traded 15 August 2022 · filed 16 August 2022
- had shares withheld for tax on 6,664 shares of ClearPoint NeuroSEC Form 412 July 2022Common Stock · traded 9 July 2022 · filed 12 July 2022
- was granted 46,742 shares of ClearPoint Neuro (a derivative holding)SEC Form 414 June 2022Stock Options (right to buy) · traded 10 June 2022 · filed 14 June 2022
- was granted 70,113 shares of ClearPoint NeuroSEC Form 414 June 2022Common Stock · traded 10 June 2022 · filed 14 June 2022
- ▼ sold on the open market 10,000 shares of ClearPoint NeuroSEC Form 412 November 2021Common Stock · traded 11 November 2021 · filed 12 November 2021
- ▼ sold on the open market 9,637 shares of ClearPoint NeuroSEC Form 421 September 2021Common Stock · traded 21 September 2021 · filed 21 September 2021
- was granted 29,377 shares of ClearPoint Neuro (a derivative holding)SEC Form 423 August 2021Stock Options (right to buy) · traded 20 August 2021 · filed 23 August 2021
- was granted 14,688 shares of ClearPoint NeuroSEC Form 423 August 2021Common Stock · traded 20 August 2021 · filed 23 August 2021
- had shares withheld for tax on 7,353 shares of ClearPoint NeuroSEC Form 417 August 2021Common Stock · traded 15 August 2021 · filed 17 August 2021
- had shares withheld for tax on 3,277 shares of ClearPoint NeuroSEC Form 413 July 2021Common Stock · traded 9 July 2021 · filed 13 July 2021
- ▼ sold on the open market 25,000 shares of ClearPoint NeuroSEC Form 422 June 2021Common Stock · traded 21 June 2021 · filed 22 June 2021
- had shares withheld for tax on 5,765 shares of ClearPoint NeuroSEC Form 45 January 2021Common Stock · traded 7 November 2020 · filed 5 January 2021
- had shares withheld for tax on 14,286 shares of ClearPoint NeuroSEC Form 49 November 2020Common Stock · traded 7 November 2020 · filed 9 November 2020
- had shares withheld for tax on 2,491 shares of ClearPoint NeuroSEC Form 418 August 2020Common Stock · traded 15 August 2020 · filed 18 August 2020
- had shares withheld for tax on 5,763 shares of ClearPoint NeuroSEC Form 410 August 2020Common Stock · traded 7 August 2020 · filed 10 August 2020
- was granted 52,356 shares of ClearPoint Neuro (a derivative holding)SEC Form 413 July 2020Stock Options (right to buy) · traded 9 July 2020 · filed 13 July 2020
- was granted 30,864 shares of ClearPoint NeuroSEC Form 413 July 2020Common Stock · traded 9 July 2020 · filed 13 July 2020
- had shares withheld for tax on 6,627 shares of ClearPoint NeuroSEC Form 48 May 2020Common Stock · traded 7 May 2020 · filed 8 May 2020
- had shares withheld for tax on 5,590 shares of Mri InterventionsSEC Form 411 February 2020Common Stock · traded 7 February 2020 · filed 11 February 2020
- had shares withheld for tax on 5,590 shares of Mri InterventionsSEC Form 412 November 2019Common Stock · traded 7 November 2019 · filed 12 November 2019
- was granted 74,404 shares of Mri Interventions (a derivative holding)SEC Form 419 August 2019Stock Options (right to buy) · traded 15 August 2019 · filed 19 August 2019
- was granted 36,023 shares of Mri InterventionsSEC Form 419 August 2019Common Stock · traded 15 August 2019 · filed 19 August 2019
- had shares withheld for tax on 5,590 shares of Mri InterventionsSEC Form 48 August 2019Common Stock · traded 7 August 2019 · filed 8 August 2019
- had shares withheld for tax on 5,590 shares of Mri InterventionsSEC Form 48 May 2019Common Stock · traded 7 May 2019 · filed 8 May 2019
- had shares withheld for tax on 23,053 shares of Mri InterventionsSEC Form 427 February 2019Common Stock · traded 7 November 2018 · filed 27 February 2019
- had shares withheld for tax on 6,475 shares of Mri InterventionsSEC Form 411 February 2019Common Stock · traded 7 February 2019 · filed 11 February 2019
- was granted 20,313 shares of Mri InterventionsSEC Form 425 January 2019Common Stock · traded 23 January 2019 · filed 25 January 2019
- had shares withheld for tax on 8,304 shares of Mri InterventionsSEC Form 425 January 2019Common Stock · traded 23 January 2019 · filed 25 January 2019
- ▲ bought on the open market 25,000 shares of Mri InterventionsSEC Form 425 September 2018Common Stock · traded 25 September 2018 · filed 25 September 2018
- ▲ bought on the open market 4,637 shares of Mri InterventionsSEC Form 424 August 2018Common Stock · traded 22 August 2018 · filed 24 August 2018
- ▲ bought on the open market 7,500 shares of Mri InterventionsSEC Form 424 August 2018Common Stock · traded 24 August 2018 · filed 24 August 2018
- ▲ bought on the open market 7,500 shares of Mri InterventionsSEC Form 423 May 2018Common Stock · traded 21 May 2018 · filed 23 May 2018
- was granted 18,867 shares of Mri InterventionsSEC Form 423 May 2018Common Stock · traded 22 May 2018 · filed 23 May 2018
- was granted 200,000 shares of Mri InterventionsSEC Form 47 November 2017Common Stock · traded 7 November 2017 · filed 7 November 2017
- was granted 350,000 shares of Mri Interventions (a derivative holding)SEC Form 47 November 2017Stock Options (right to buy) · traded 7 November 2017 · filed 7 November 2017
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.